GW Pharmaceuticals’ Epidiolex Wins New FDA Approvals

GW Pharmaceuticals’ Epidiolex Wins New FDA Approvals

GW Pharmaceuticals’ (NASDAQ:GWPH) cannabidiol (CBD) drug Epidiolex has been granted Food and Drug Administration approval for a new indication. Additionally, its previous approval has been expanded t…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *